Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
PEGylated Proteins Market
... the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed ... Read More
-
Global Erythropoietin Drugs Databank Market Report
... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More
-
Biologics and Biosimilars Industry Research Report 2024
... proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. ... Read More
-
Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030
... proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in ... Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
Human Insulin Market Size, Trends, Analysis, and Outlook By Product (Drugs, Delivery Devices), By Drug (Insulin Analogs and Biosimilars, Human Insulin Biologics), By Brand (Insulin Analogs and Biosimilars, Human Insulin Biologics, Insulatard, Mixtard), By Delivery Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032
... Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032 The global Human Insulin market size is poised to register 4.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in ... Read More
-
Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Biosimilars market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilars market across ... Read More
-
Bioprocess Analyzers Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables), By Application (Antibiotics, Recombinant Proteins, Biosimilars, Others), By Type (Substrate Analysis, Metabolite Analysis, Concentration Detection), by Country, Segment, and Companies, 2024-2032
... Bioprocess Analyzers market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Bioprocess Analyzers market across By ... Read More
-
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global oncology biosimilars market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion ... Read More
-
Biosimilars Market based on by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook– Global Forecast up to 2032
... a high priority on the development of biosimilars. By December 2022, 25 biosimilars had been introduced in the US and 40 had received FDA approval. FDA approvals fell off dramatically during the COVID-19 pandemic, but ... Read More
-
Aseptic Connectors Market - A Global and Regional Analysis: Focus on Type, Product, End User and Region - Analysis and Forecast, 2023-2033
... at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033. The global aseptic connectors market is a dynamic and rapidly evolving ... Read More
-
2024 Global: Biosimilars Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Biosimilar Monoclonal Antibodies Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global Forecast for Bioprocess Containers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Traumatic Brain Injury Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Acetylcholinesterase Inhibitors, Erythropoietin, Growth Hormone, Stem Cells, Others), By Application (Local TBI, Open TBI, Closed TBI, Diffuse TBI, Primary TBI, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Traumatic Brain Injury Therapeutics market size is poised to register 5.56% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
mAb Biosimilars Market Size, Trends, Analysis, and Outlook By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End-User (Hospitals, Cancer Treatment centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global mAb Biosimilars market size is poised to register 8.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mAb ... Read More
-
Oncology Biosimilars Market Size, Trends, Analysis, and Outlook By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer, Others), By Drug Class (Monoclonal Antibodies, Granulocyte Colony-Stimulating Factor, Others), By Route of Administration (Intravenous, Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others), by Region, Country, Segment, and Companies, 2024-2030
... Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Oncology Biosimilars market size is poised to register 8.84% growth (CAGR) from 2024 to 2030, presenting significant ... Read More
-
Biologics Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Biologics, Biosimilars), By Application (Outsourced, In-house), by Region, Country, Segment, and Companies, 2024-2030
... (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biologics Manufacturing market By Type (Biologics, Biosimilars), By Application (Outsourced, In-house). In biologics manufacturing, ... Read More
-
Global Glycosylated Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Glycosylated Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Glycosylated Biosimilars ... Read More
-
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Peptides Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Peptides Biosimilars ... Read More
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Recombinant Non-Glycosylated Proteins Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
Research Assistance
